[{"knownEffect":null,"nccnGuidelines":[],"levelOfEvidence":null,"treatments":[],"articles":[],"clinicalTrials":[],"evidenceId":7051,"evidenceType":"GENE_SUMMARY","alterations":[],"description":"description","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"summray","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"tumorType":null},{"knownEffect":null,"nccnGuidelines":[],"levelOfEvidence":null,"treatments":[],"articles":[{"pages":"875-85","authors":"Wellbrock C et al","journal":"Nature reviews. Molecular cell biology","pubDate":"2004 Nov","volume":"5","issue":"11","elocationId":"","articleId":1829,"reference":"Wellbrock C et al. Nature reviews. Molecular cell biology. 2004 Nov;5(11)875-85.","pmid":"15520807","title":"The RAF proteins take centre stage."}],"clinicalTrials":[],"evidenceId":7052,"evidenceType":"GENE_BACKGROUND","alterations":[],"description":"description","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"description","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"tumorType":null},{"knownEffect":"Activating","nccnGuidelines":[],"levelOfEvidence":null,"treatments":[],"articles":[{"pages":"855-67","authors":"Wan PT et al","journal":"Cell","pubDate":"2004 Mar 19","volume":"116","issue":"6","elocationId":"","articleId":1830,"reference":"Wan PT et al. Cell. 2004 Mar 19;116(6)855-67.","pmid":"15035987","title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF."},{"pages":"949-54","authors":"Davies H et al","journal":"Nature","pubDate":"2002 Jun 27","volume":"417","issue":"6892","elocationId":"","articleId":233,"reference":"Davies H et al. Nature. 2002 Jun 27;417(6892)949-54.","pmid":"12068308","title":"Mutations of the BRAF gene in human cancer."}],"clinicalTrials":[],"evidenceId":7053,"evidenceType":"MUTATION_EFFECT","alterations":[{"refResidues":"V","proteinStart":600,"proteinEnd":600,"variantResidues":"E","alterationType":"MUTATION","consequence":{"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved","isGenerallyTruncating":false,"term":"missense_variant"},"oncogenic":true,"alterationId":1095,"name":"V600E","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"summary","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"alteration":"V600E"}],"description":"description","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"summary","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"tumorType":null},{"knownEffect":null,"nccnGuidelines":[],"levelOfEvidence":null,"treatments":[],"articles":[{"pages":"251-63","authors":"Hodis E et al","journal":"Cell","pubDate":"2012 Jul 20","volume":"150","issue":"2","elocationId":"doi: 10.1016/j.cell.2012.06.024","articleId":258,"reference":"Hodis E et al. Cell. 2012 Jul 20;150(2)251-63.","pmid":"22817889","title":"A landscape of driver mutations in melanoma."}],"clinicalTrials":[],"evidenceId":7054,"evidenceType":"PREVALENCE","alterations":[{"refResidues":"V","proteinStart":600,"proteinEnd":600,"variantResidues":"E","alterationType":"MUTATION","consequence":{"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved","isGenerallyTruncating":false,"term":"missense_variant"},"oncogenic":true,"alterationId":1095,"name":"V600E","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"summary","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"alteration":"V600E"}],"description":"description","gene":{"hugoSymbol":"BRAF","geneAliases":["B-RAF1","BRAF1","RAFB1","NS7"],"summary":"summary","geneLabels":[],"name":"B-Raf proto-oncogene, serine/threonine kinase","status":"","entrezGeneId":673},"tumorType":{"tumorTypeId":"Melanoma, malignant","tissue":null,"name":"Melanoma, malignant","shortName":null,"clinicalTrialKeywords":["Melanoma, malignant"]}}]